Date:05-May-2024  Time: 11:12 PM
 
 
        
Kilitch Drugs (India) Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales29.7731.5731.1243.28
Other Income3.400.920.981.43
Total Income33.1632.4932.1044.71
Total Expenditure 25.7525.7325.8936.60
Operating Profit7.416.766.228.12
Interest0.530.550.380.41
Gross Profit6.886.215.847.71
Depreciation0.300.280.260.37
Tax1.301.761.992.04
Deferred Tax-0.22-0.07-0.590.17
Reported Profit After Tax5.504.244.195.13
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com